Early research (Phase 1)Study completedNCT01204866
What this trial is testing
Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use
Who this might be right for
Allergic Reactions
PharmAthene, Inc. 5
Showing 2 of 2 results